Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:01 PM UTC
| NCT Number | NCT07221253 |
| Recruiting Status | Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,100 participants |
| Active Locations | 42 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07221253 is currently recruiting participants. This phase3 study for biliary tract cancer is actively seeking new participants at 42 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221253 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221253 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.